美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Innovate Biopharmaceuticals, Inc.

0.5600

+0.0000

成交量：- -

成交額：- -

市值：2,314.20萬

市盈率：-0.69

高：0.5600

開：0.5600

低：0.5600

收：0.5600

資料載入中...

總覽公司新聞公告

公司資料

公司名字：

Innovate Biopharmaceuticals, Inc.

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.innovatebiopharma.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Innovate Biopharmaceuticals, Inc.是一家臨床階段的生物技術公司，專註於開發針對自身免疫/炎症疾病的新藥。該公司的業務範圍包括腹腔疾病，未滿足的需求和潰瘍性結腸炎的候選藥物。由強大的管理團隊引領創新，具有藥物開發的廣泛經驗和將新型療法推向市場的歷史。公司在全球擁有超過150項專利的產品。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/INNT/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"INNT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INNT\",,,,,undefined,":{"symbol":"INNT","market":"US","secType":"STK","nameCN":"Innovate Biopharmaceuticals, Inc.","latestPrice":0.56,"timestamp":1588363200000,"preClose":0.56,"halted":8,"volume":0,"delay":0,"floatShares":31401489,"shares":41324976,"eps":-0.811579,"marketStatus":"盤後交易","change":0,"latestTime":"05-02 16:30:25 EDT","open":0.56,"high":0.56,"low":0.56,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.811579,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1746230400000},"marketStatusCode":4,"symbolChange":{"newSymbol":"NMTR","executeDate":"2020-05-04"},"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":0.56,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INNT\",,,,,undefined,":{"symbol":"INNT","floatShares":31401489,"roa":"-258.31%","roe":"407.57%","lyrEps":-0.811579,"shares":41324976,"dividePrice":0,"high":0.56,"amplitude":0,"preClose":0.56,"low":0.56,"week52Low":0.3701,"pbRate":"4.62","week52High":1.67,"institutionHeld":0,"latestPrice":0.56,"eps":-0.811579,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.811579,"open":0.56},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.innovatebiopharma.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0215},{"period":"1month","weight":-0.0045},{"period":"3month","weight":-0.072},{"period":"6month","weight":-0.022},{"period":"1year","weight":0.1162},{"period":"ytd","weight":-0.0471}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Innovate Biopharmaceuticals, Inc.是一家臨床階段的生物技術公司，專註於開發針對自身免疫/炎症疾病的新藥。該公司的業務範圍包括腹腔疾病，未滿足的需求和潰瘍性結腸炎的候選藥物。由強大的管理團隊引領創新，具有藥物開發的廣泛經驗和將新型療法推向市場的歷史。公司在全球擁有超過150項專利的產品。","exchange":"NASDAQ","name":"Innovate Biopharmaceuticals, Inc.","nameEN":"Innovate Biopharmaceuticals, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"INNT\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/INNT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-05-08","symbol":"INNT","fiscalQuarterEnding":"2020/03","expectedEps":-0.13,"name":null,"time":"","type":"earning","dateTimestamp":1588910400000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2020-05-04","symbol":"INNT","oldSymbol":"INNT","newSymbol":"NMTR","exchange":"NASDAQ","type":"symbolChange","dateTimestamp":1588564800000},{"market":"US","date":"2020-03-20","symbol":"INNT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1584676800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2019-11-07","symbol":"INNT","fiscalQuarterEnding":"2019/09","expectedEps":-0.14,"name":null,"time":"","type":"earning","dateTimestamp":1573102800000,"reportTimeType":"","actualEps":-0.19},{"date":"2019-08-08","symbol":"INNT","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2019/06","expectedEps":-0.16,"defaultRemindTime":1565251200000,"name":null,"time":"盤前","dateTimestamp":1565236800000,"actualEps":-0.16}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"INNT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"INNT\",market:\"US\",delay:false,,,undefined,":{}}}